Table 1—

Clinical characteristics at randomization

PlaceboOrlistat
n269266
Sex
 Male118 (44)116 (44)
 Female151 (56)150 (56)
Race
 Caucasian196 (73)189 (71)
 African-American43 (16)45 (17)
 Asian2 (1)5 (2)
 Other28 (10)27 (10)
Age (years)58.0 ± 0.557.8 ± 0.5
Weight (kg)101.8 ± 1.0102.0 ± 1.0
Height (cm)168.9 ± 0.6168.5 ± 0.6
BMI35.6 ± 0.335.8 ± 0.2
HbA1c (%)8.99 ± 0.079.01 ± 0.07
Fasting glucose (mmol/l)11.16 ± 0.210.91 ± 0.2
Daily dosages of diabetes medications
 Insulin (units/day)84.0 ± 671.3 ± 1
 Sulfonylurea (mg/day)67.6 ± 6.560.75 ± 7.0
 Metformin (mg/day)1,207 ± 1051,287 ± 104
Diabetes medications (%)
 Insulin only69.972.9
 Insulin + metformin16.012.8
 Insulin + sulfonylurea10.06.8
 Insulin + metformin + sulfonylurea3.34.5
  • Data are n (%) or means ± SE, unless otherwise indicated.